 |
|
|
 |
- A Phase I Trial of Doxorubicin and Flavopiridol in the Treatment of Metastatic Sarcoma
D'Adamo, David, MD
[Protocol 04-075]
- A Phase I/II Study of Temsirolimus (CCI-779) in Children with Relapsed or Refractory Solid Tumors (Part 2)
Dunkel, Ira, MD
[Protocol 07-060]
- A Phase II Study of LY573636 as Second-line or Third-line Treatment in Patients with Unresectable or Metastatic Soft-Tissue Sarcoma
Keohan, Mary, MD
[Protocol 07-177]
- A Phase II Study of Sorafenib (BAY 43-9006) for Patients with Imatinib-Resistant Malignant Gastrointestinal Stromal Tumor (GIST)
D'Adamo, David, MD
[Protocol 06-028]
- A Phase II Trial of Intravenous Myeloablative Chemotherapy Followed by an Allogeneic Hematopoietic Stem Cell Transplant from a Matched Relative to Treat High-Risk Ewing's Sarcoma Family Tumors
Prockop, Susan, MD
[Protocol 05-059]
- A Phase II Trial of Irinotecan plus Carboplatin, and Irinotecan Maintenance Therapy Integrated into the Upfront Therapy of Newly Diagnosed Patients with Intermediate- and High-Risk Rhabdomyosarcoma
Wexler, Leonard, MD
[Protocol 03-099]
- A Phase II Trial of R1507 for People with Recurrent Sarcoma
Maki, Robert, MD
[Protocol 07-166]
- Effect of Imatinib on Bone Metabolism, Lipid Metabolism, and Thyroid Function in Patients with Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors
Berman, Ellin, MD
[Protocol 06-142]
- Vincristine, Dactinomycin, and Lower Doses of Cyclophosphamide in Patients with Newly Diagnosed Low-Risk Embryonal/Botryoid Rhabdomyosarcoma
Wexler, Leonard, MD
[Protocol 05-032]
|
|
|
|
|
